Daily Health & Wellness Brief · September 12th

Storyflo Health — Daily Health Brief · Sep 12, 2026 · 3m

From storyflo. This is your daily audio brief. Hi, it's Chloe. September 12th. Ten in health — the one that made me re-read the abstract is at the top. Let's get into it. First, from Endpoints Pharma. Setbacks for Novartis; Anthropic looks for a dealmaker; and more. Novartis is facing some challenges lately, particularly with its gene therapy program. A recent study indicated that a treatment for a rare genetic disorder didn’t meet its effectiveness targets in a Phase 3 trial. This setback could impact their plans and timelines moving forward, which is something to keep an eye on if you’re…